Genous stent in high-risk patients with known contraindications for dual antiplatelet therapy

Trial Profile

Genous stent in high-risk patients with known contraindications for dual antiplatelet therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Jan 2011

At a glance

  • Drugs Anti-CD34 monoclonal antibody (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Sponsors OrbusNeich
  • Most Recent Events

    • 11 Jan 2011 New trial record
    • 10 Jan 2011 Results have been published online in EuroIntervention, according to an Orbus Neich media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top